← Leaderboards
Anna Marie Eiring
Texas Tech University Health Scis Center
$1,184,010
Attributed
$1,184,010
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $480K · FY2018–24$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,184,010 · 2
By mechanism
K22$704,010 · 1
R15$480,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsIn VivoMolecularResponseMouse ModelCareerKnockout MiceLinkPathway InteractionsRegulationPhenotypeOxidative PhosphorylationBindingChronicApoptosisChronic Myeloid LeukemiaChronic Myeloid Leukemia CellGrowthChronic PhaseHypermethylationImatinibCell PhysiologyAlternative TreatmentDrug Resistance
Grant awards (5)
G0S2 and lipid metabolism in the regulation of hematopoietic development$480,000
R15 · FY2024 · HL · contact PI
G0S2 in chronic myeloid leukemia disease progression and imatinib resistance$119,800
K22 · FY2021 · CA · contact PI
G0S2 in Chronic Myeloid Leukemia Disease Progression and Imatinib Resistance$195,590
K22 · FY2020 · CA · contact PI
G0S2 in Chronic Myeloid Leukemia Disease Progression and Imatinib Resistance$195,590
K22 · FY2019 · CA · contact PI
G0S2 in Chronic Myeloid Leukemia Disease Progression and Imatinib Resistance$193,030
K22 · FY2018 · CA · contact PI